Development, Validation, and Innovation in Ophthalmic Laser-Based Imaging: Report From a US Food and Drug Administration-Cosponsored Forum.
Journal Article
In April 2019, the US Food and Drug Administration, in conjunction with 11 professional ophthalmic, vision science, and optometric societies, convened a forum on laser-based imaging. The forum brought together the Food and Drug Administration, clinicians, researchers, industry members, and other stakeholders to stimulate innovation and ensure that patients in the US are the first in the world to have access to high-quality, safe, and effective medical devices. This conference focused on the technology, clinical applications, regulatory issues, and reimbursement issues surrounding innovative ocular imaging modalities. Furthermore, the emerging role of artificial intelligence in ophthalmic imaging was reviewed. This article summarizes the presentations, discussion, and future directions.
Full Text
Duke Authors
Cited Authors
- Brodie, F; Repka, M; Burns, SA; Prakalapakorn, SG; Morse, C; Schuman, JS; Duenas, MR; Afshari, N; Pollack, JS; Thorne, JE; Vitale, A; Sen, HN; Myung, D; Blumenkranz, MS; Tu, E; Hammer, DX; Tarver, M; Cunningham, B; Kagemann, L; Sadda, S; Sarraf, D; Jaffe, GJ; Eydelman, M
Published Date
- January 1, 2021
Published In
Volume / Issue
- 139 / 1
Start / End Page
- 113 - 118
PubMed ID
- 33211074
Pubmed Central ID
- PMC8005310
Electronic International Standard Serial Number (EISSN)
- 2168-6173
Digital Object Identifier (DOI)
- 10.1001/jamaophthalmol.2020.4994
Language
- eng
Conference Location
- United States